Selective and Nonselective Cyclooxygenase-2 Inhibitors and Experimental Fracture-Healing

Gerstenfeld, L. C.; Al-Ghawas, M.; Alkhiary, Y. M.; Cullinane, D.M.; Krall, E.A.; Fitch, J. L.; Webb, E. G.; Thiede, M. A.; Einhorn, T. A.
January 2007
Journal of Bone & Joint Surgery, American Volume;Jan2007, Vol. 89-A Issue 1, p114
Academic Journal
Background: Cyclooxygenase-2-specific anti-inflammatory drugs (coxibs) and nonspecific nonsteroidal anti-inflammatory drugs have been shown to inhibit experimental fracture-healing. The present study tested the hypothesis that these effects are reversible after short-term treatment. Methods: With use of a standard model of fracture-healing, identical ED5O dosages of either a nonsteroidal anti- inflammatory drug (ketorolac), a coxib (valdecoxib), or vehicle (control) were orally administered to rats for either seven or twenty-one days and fracture-healing was assessed with biomechanical, histological, and biochemical analyses. Results: When healing was assessed at twenty-one days, the seven-day treatment produced only a trend for a higher rate of nonunion in valdecoxib and ketorolac-treated animals as compared with controls. No differences were observed at thirty-five days. The twenty-one-day treatment produced significantly more nonunions in valdecoxib-treated animals as compared with either ketorolac-treated or control animals (p < 0.05), but these differences disappeared by thirty-five days. The dose-specific inhibition of these drugs on prostaglandin E2 levels and the reversibility of the effects after drug withdrawal were assessed in fracture calluses and showed that ketorolac treatment led to twofold to threefold lower levels of prostaglandin E2 than did valdecoxib. Withdrawal of either drug after six days led to a twofold rebound in these levels by fourteen days. Histological analysis showed delayed remodeling of calcified cartilage and reduced bone formation in association with valdecoxib treatment. Conclusions: Cyclooxygenase-2-specific drugs inhibit fracture-healing more than nonspecific nonsteroidal anti- inflammatory drugs, and the magnitude of the effect is related to the duration of treatment. However, after the discontinuation of treatment, prostaglandin E2 levels are gradually restored and the regain of strength returns to levels similar to control. Clinical Relevance: While animal studies have suggested that both nonsteroidal anti-inflammatory drugs and coxibs inhibit bone repair, there have been no clinical reports with Level-i evidence to support these findings. Because most patients discontinue these medications when pain has subsided, it is important to determine whether the inhibitory effects are reversible. The present animal study confirms that inhibition of cyclooxygenase 2 impairs fracture-healing and that the effects are dependent on both the dose and duration of treatment. However, the reduced prostaglandin levels in callus rebound with drug withdrawal, and the impairment in the mechanical integrity of the healing fractures is reversed after short-term treatment.


Related Articles

  • Dose and Time-Dependent Effects of Cyclooxygenase-2 Inhibition on Fracture-Healing. Simon, Ann Marie; O'Connor, J. Patrick // Journal of Bone & Joint Surgery, American Volume;Mar2007, Vol. 89-A Issue 3, p500 

    Background: Fracture-healing is impaired in mice lacking a functional cyclooxygenase-2 (COX-2) gene or in rats continuously treated with COX-2 inhibitors. These observations indicate that COX-2 is a critical regulator of fracture repair. Nonsteroidal anti-inflammatory drugs are commonly used to...

  • Effects of a selective cyclooxygenase - 2 inhibitor (celecoxib) on fracture healing in rats. Kang‑Hua Li; Liang Cheng; Yong Zhu; Guo‑Bing Deng; Hai‑Tao Long // Indian Journal of Orthopaedics;Jul-Aug2013, Vol. 47 Issue 4, p395 

    Background: Several studies suggested that celecoxib interferes with bone healing while others contradict these findings. This study was conducted to investigate the effects of celecoxib on bone healing in rats femur mold with a dose based on body surface area conversion. Materials and Methods:...

  • Negative effects of parecoxib and indomethacin on tendon healing: an experimental study in rats. Dimmen, Sigbjorn; Engebretsen, Lars; Nordsletten, Lars; Madsen, Jan Erik // Knee Surgery, Sports Traumatology, Arthroscopy;Oct2009, Vol. 17 Issue 7, p835 

    Conventional non-steroidal anti-inflammatory drugs (NSAIDs) and newer specific cyclooxygenase-2 (cox-2) inhibitors are commonly used in muscular skeletal trauma and in relation to orthopedic surgery to reduce the inflammatory response and pain. Studies have indicated that these drugs can have a...

  • The effects of AZD3582 [4-(nitroxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate], and naproxen on key pathogenic steps in NSAID-enteropathy in the rat. Walley, M.; Sigthorsson, G.; Hotz-Behofsits, C.; Simpson, R.; Bjarnason, I. // Inflammopharmacology;Jun2007, Vol. 15 Issue 3, p119 

    The pathogenesis of NSAID-induced enteropathy may involve dual inhibition of the cyclooxygenase (1 and 2) and a topical effect with sequential increased intestinal permeability, development of inflammation and ulcers. It has been suggested that nitric-oxide donating drugs cause significantly...

  • Tempering the Enthusiasm for COX-2 Inhibitors. Nuovo, James // American Family Physician;6/15/2000, Vol. 61 Issue 12, p3560 

    Editorial. Deals with cyclooxygenase (COX) inhibitors, a class of anti-inflammatory medications that have been introduced for use in the United States. Inhibition of nonsteroidal anti-inflammatory drugs (NSAID); Role in prostaglandin synthesis; Analgesic efficacy of COX-2 inhibitors and NSAID.

  • The effect of nonsteroidal anti-inflammatory drugs on tissue healing. Chen, Michael; Dragoo, Jason // Knee Surgery, Sports Traumatology, Arthroscopy;Mar2013, Vol. 21 Issue 3, p540 

    Purpose: Non-selective (NSAIDs) and selective (COX-2) nonsteroidal anti-inflammatory drugs are commonly used for their analgesic and anti-inflammatory effects. Their role after orthopaedic surgery has been infrequently described and remains controversial because of unclear effects on soft tissue...

  • Do COX Inhibitors Slow Fracture Union and Bone Ingrowth? Sorbie, Charles // Orthopedics;Jan2003, Vol. 26 Issue 1, p19 

    Presents two studies which argued against using cyclooxygenases inhibitors after fractures or after implanting prostheses that rely on bone ingrowth to porous surfaces for fixation and reported a significantly increased risk to fracture union in patients taking NSAIDS. Highlights of both studies.

  • Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats. Dudhgaonkar, S. P.; Tandan, S. K.; Kumar, D.; Raviprakash, V.; Kataria, M. // Inflammopharmacology;Oct2007, Vol. 15 Issue 5, p188 

    The inflamed mucosa in ulcerative colitis produces high amount of prostaglandin (PG) and nitric oxide (NO) through inducible enzymes: cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), respectively, implicating them as potential anti-inflammatory drug targets. COX-2 or...

  • Enhanced Plasma Concentration by Selective Deuteration of Rofecoxib in Rats. Schneider, Frank; Hillgenberg, Moritz; Koytchev, Rossen; Alken, Rudolf-Giesbert // Drug Research / Arzneimittel-Forschung (Editio Cantor Verlag fur;Apr2006, Vol. 56 Issue 4, p295 

    The plasma concentrations of BDD-11602 (4-[4-(methanesulfonyl)phenyl]-3-(pentadeuterophenyl)-5H-furan-2-one), a rofecoxib derivative in which the positions 2′, 3′, 4′, 5′ and 6′ of the phenyl ring were deuterated, and rofecoxib...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics